Out-Patient Consolidation Therapy in Patients with AML by Mitoxan-trone, Etoposide and Cytarabine

Out-Patient Consolidation Therapy in Patients with AML by Mitoxan-trone, Etoposide and Cytarabine

History and Goals: Now a days, the main purpose of treatment in patients with Acute Myeloid Leukemia (AML), is achiev¬ing a "definite cure", and this goal is impossible unless stem cell transplantation (bone marrow transplantation) or the ad¬ministration of high-dose Cytarabine is perform...

Full description

Bibliographic Details
Main Authors:	A Shahriari Ahmadi, M Aznab
Format:	Article
Language:	English
Published:	Tehran University of Medical Sciences 2004-03-01
Series:	International Journal of Hematology-Oncology and Stem Cell Research
Subjects:	Consolidation therapy Etoposide Cytarabine
Online Access:	https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/171

Similar Items

Out-Patient Consolidation Therapy in Patients with AML by Mitoxan-trone, Etoposide and Cytarabine
by: Shahriari Ahmadi A, et al.
Published: (2004-08-01)

Comparison of Ifosfamide, Carboplatin and Etoposide versus Etoposide, Steroid, and Cytarabine Cisplatin as Salvage Chemotherapy in Patients with Refractory or Relapsed Hodgkin's lymphoma
by: Valiollah Mehrzad, et al.
Published: (2017-01-01)

Possible benefit of consolidation therapy with high-dose cytarabine on overall survival of adults with non-promyelocytic acute myeloid leukemia
by: M.C. Azevedo, et al.
Published: (2015-02-01)

Novel formulation of cytarabine and daunorubicin: A new hope in AML treatment
by: Lalit S Raut
Published: (2015-01-01)

Hypersensitivity reaction to etoposide. A case report
by: M. Mullera Martí, et al.
Published: (2014-05-01)

Methotrexate and Cytarabine—Loaded Nanocarriers for Multidrug Cancer Therapy. Spectroscopic Study
by: Danuta Pentak, et al.
Published: (2016-12-01)

Reformulating acute myeloid leukemia: liposomal cytarabine and daunorubicin (CPX-351) as an emerging therapy for secondary AML
by: Chen EC, et al.
Published: (2018-06-01)

Histological Effects of Cytarabine on Liver and Buccal Mucosa in Mice
by: Ghasaq A. Dawood, et al.
Published: (2020-04-01)

The bioavailability of cytarabine in dogs with meningoencephalitis of unknown etiology through iontophoresis and rectal delivery
by: Shelby L. Mancini, et al.
Published: (2021-01-01)

Etoposide Therapy for Recurrent Gliomas
by: J Gordon Millichap
Published: (1997-06-01)

Cytarabine-Induced Corneal Toxicity: Clinical Features and Relief of Symptoms with Loteprednol Etabonate 0.5% in Two Patients
by: Gökçen Özcan, et al.
Published: (2021-04-01)

The histological changes induced by Cytarabine on rabbits livers (with and without vitamin E administration)
by: Saif Al-Jammas, et al.
Published: (2020-01-01)

Role of low dose cytarabine in elderly patients with acute myeloid leukemia: An experience
by: Yasir Bashir, et al.
Published: (2015-01-01)

Biodistribution of etoposide via intratumoral chemotherapy with etoposide-loaded implants
by: Chunsheng Wu, et al.
Published: (2020-01-01)

Hypersensitivity to Etoposide in Case of Metastatic Gestational Choriocarcinoma
by: Biljana Lazović, et al.
Published: (2013-09-01)

The histological changes induced by cytarabine on rabbits kidneys (with and without vitamin E administration)
by: Saif Al-Jammas, et al.
Published: (2019-09-01)

Disrupting the LC3 Interaction Region (LIR) Binding of Selective Autophagy Receptors Sensitizes AML Cell Lines to Cytarabine
by: Mateusz Putyrski, et al.
Published: (2020-03-01)

Studies on the effect of palmitylcarnitine chloride on the solubility of etoposide : thesis ...
by: Kashyap, Lola
Published: (1988)

Natural Polyphenols as Modulators of Etoposide Anti-Cancer Activity
by: Magdalena Kluska, et al.
Published: (2021-06-01)

Pharmacokinetics of multivesicular liposomal encapsulated cytarabine when administered subcutaneously in dogs
by: Irene B. Vazquez Fuster, et al.
Published: (2020-07-01)

"Time sequential high dose of Cytarabine in acute myelocytic leukemia "
by: Ghavamzadeh A, et al.
Published: (2003-05-01)

"Time sequential high dose of Cytarabine in acute myelocytic leukemia "
by: Ghavamzadeh A, et al.
Published: (2003-03-01)

Homoharringtonine combined with aclarubicin and cytarabine synergistically induces apoptosis in t(8;21) leukemia cells and triggers caspase‐3‐mediated cleavage of the AML1‐ETO oncoprotein
by: Jiang Cao, et al.
Published: (2016-11-01)

Nucleoside transporter-guided cytarabine-conjugated liposomes for intracellular methotrexate delivery and cooperative choriocarcinoma therapy
by: Weidong Fei, et al.
Published: (2021-06-01)

Determination of solution structure of anti-cancer drug etoposide by NMR and computer simulation
by: Zhang, Kangling
Published: (1997)

Adult Burkitt lymphoma: An institutional experience with a uniform chemotherapy protocol
by: Mukesh Patekar, et al.
Published: (2018-01-01)

Auricular Oedema and Dyshidrotic Eczema in a Patient with Acute Myeloid Leukaemia Treated with Cytarabine
by: K. Brandt, et al.
Published: (2010-10-01)

Successful Treatment of Erythrodermic Mycosis Fungoides with Mogamulizumab Followed by Etoposide Monotherapy
by: Taku Fujimura, et al.
Published: (2018-01-01)

Preferential induction of MLL (Mixed Lineage Leukemia) rearrangements in human lymphocyte cultures treated with etoposide
by: María Sol Brassesco, et al.
Published: (2009-01-01)

Inhibition of Autophagy Does Not Re-Sensitize Acute Myeloid Leukemia Cells Resistant to Cytarabine
by: Nienke Visser, et al.
Published: (2021-02-01)

MicroRNA-mRNA Pairs Associated with Outcome in AML: From in vitro Cell-based Studies to AML Patients
by: Neha S Bhise, et al.
Published: (2016-01-01)

Maintenance therapy with oral etoposide following first-line docetaxel-cisplatin chemotherapy in metastatic non-small cell lung cancer patients
by: Meiyu Fang, et al.
Published: (2012-09-01)

Effects of intensive induction and consolidation chemotherapy with idarubicin and high dose cytarabine on minimal residual disease levels in newly diagnosed adult precursor-B acute lymphoblastic leukemia
by: Kenneth F. Bradstock, et al.
Published: (2016-12-01)

Successful treatment of mycobacterial infection associated hemophagocytic lymphohistiocytosis with etoposide and anti-tuberculous therapy: a case report
by: Yan-Hong Wang, et al.
Published: (2020-05-01)

Cellular Metabolomics Profiles Associated With Drug Chemosensitivity in AML
by: Bradley Stockard, et al.
Published: (2021-06-01)

TREATMENT WITH LOW-DOSE CYTARABINE IN ELDERLY PATIENTS (AGE 70 YEARS OR OLDER) WITH ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION EXPERIENCE
by: Maël Heiblig, et al.
Published: (2016-01-01)

Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor
by: Sachiko Ezoe
Published: (2012-07-01)

Structural and Biochemical Basis of Etoposide-Resistant Mutations in Topoisomerase IIα
by: Deweese, J.E, et al.
Published: (2022)

Effect of Etoposide Treatment on ERG Transfected H358 Cell Line
by: Emine Kandemiş, et al.
Published: (2018-12-01)

The effect of cephalexin in influencing the pharmacokinetics of a novel drug – 5′-valyl-cytarabine hydrochloride
by: Xiaotong Song, et al.
Published: (2017-03-01)